Aryeh Jason

Aryeh Jason is listed in filings as Director at Orchestra BioMed Holdings, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including purchase activity and sale activity. Recent filings connect the profile to Orchestra BioMed Holdings, Inc. (OBIO), Ligand Pharmaceuticals Incorporated - Common Stock (LGND), Lifecore Biomedical, Inc. (LFCR), and Anebulo Pharmaceuticals, Inc. (ANEB). The current snapshot covers public activity from Jun 17, 2024 to Jun 25, 2026. Reported amounts are shown as $171.9K to $50.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.